Cheryl Guttman Krader, BS, Pharm

Patients are at risk for developing severe dry eye and ocular surface disease.

Early experience with next-generation lens engenders positive perception.

Dual imaging may reduce costs, unnecessary referrals, telehealth study results show.

Retrospective review highlights the sustained efficacy of combination procedure.

Investigators find increased treatment regimen is effective and long-lasting for patients.

Dexamethasone implant is key to treating non-infectious posterior segment uveitis.

Delivering existing therapeutics through alternative routes may offer option.

Investigators find treatment is an option for treating open-angle glaucoma.

Eyes with chronic disease responded to steroid treatment.

Study highlights role of demographic and socioeconomic characteristics in treatment.

Option demonstrates stable to improved visual acuity and retinal thickness.

Physicians should consider basing decisions on findings from comprehensive consultation and examination.

Protocol V delves into observation of disease.

Technology helps physicians understand normal and abnormal macular anatomy.

Tool can help physicians detect, monitor ophthalmic disease in their patients.

Key is to recognize usual patterns for systemic and topical medications.

Algorithm detects, stratifies severity of disease, facilitates early diagnosis.

DME diagnosis plays no role in determining whether patients will receive injection.

Sustained release helps mitigate disease progression without impacting quality of life.

Glaucoma Research Foundation (GRF) Ambassadors webinar provides platform for idea-sharing by ophthalmologists